Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tuberous Sclerosis | 106 | 2024 | 1042 | 14.310 |
Why?
|
TOR Serine-Threonine Kinases | 43 | 2024 | 2066 | 4.230 |
Why?
|
Spastic Paraplegia, Hereditary | 16 | 2024 | 171 | 3.530 |
Why?
|
Autistic Disorder | 21 | 2023 | 1240 | 3.270 |
Why?
|
Induced Pluripotent Stem Cells | 15 | 2024 | 1889 | 2.760 |
Why?
|
Tumor Suppressor Proteins | 34 | 2024 | 2812 | 2.530 |
Why?
|
Neurons | 42 | 2024 | 9513 | 2.510 |
Why?
|
Adaptor Protein Complex 4 | 9 | 2023 | 40 | 2.100 |
Why?
|
Epilepsy | 26 | 2024 | 3326 | 1.860 |
Why?
|
Sturge-Weber Syndrome | 8 | 2024 | 89 | 1.770 |
Why?
|
Purkinje Cells | 6 | 2021 | 228 | 1.730 |
Why?
|
Seizures | 18 | 2024 | 3000 | 1.670 |
Why?
|
Axons | 11 | 2024 | 1678 | 1.660 |
Why?
|
Cilia | 4 | 2021 | 498 | 1.650 |
Why?
|
Chromosome Disorders | 11 | 2024 | 499 | 1.620 |
Why?
|
Survival of Motor Neuron 1 Protein | 6 | 2018 | 64 | 1.600 |
Why?
|
Succinate-Semialdehyde Dehydrogenase | 4 | 2024 | 96 | 1.430 |
Why?
|
Brain | 66 | 2024 | 27454 | 1.360 |
Why?
|
Cerebellum | 8 | 2018 | 1514 | 1.310 |
Why?
|
GTPase-Activating Proteins | 3 | 2022 | 471 | 1.300 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 4 | 2024 | 284 | 1.270 |
Why?
|
Chromosome Deletion | 12 | 2024 | 1390 | 1.260 |
Why?
|
Sirolimus | 12 | 2024 | 1542 | 1.180 |
Why?
|
Rett Syndrome | 4 | 2018 | 164 | 1.110 |
Why?
|
Muscular Atrophy, Spinal | 5 | 2018 | 260 | 1.090 |
Why?
|
Spasms, Infantile | 6 | 2021 | 301 | 1.090 |
Why?
|
Signal Transduction | 31 | 2024 | 23631 | 1.030 |
Why?
|
ARNTL Transcription Factors | 2 | 2017 | 97 | 1.020 |
Why?
|
Disease Models, Animal | 29 | 2024 | 18362 | 1.020 |
Why?
|
Behavior, Animal | 6 | 2020 | 1879 | 1.010 |
Why?
|
Hamartoma Syndrome, Multiple | 6 | 2024 | 115 | 1.000 |
Why?
|
Developmental Disabilities | 10 | 2024 | 1516 | 0.950 |
Why?
|
Autophagy | 7 | 2021 | 1351 | 0.900 |
Why?
|
Pentylenetetrazole | 2 | 2021 | 72 | 0.900 |
Why?
|
Convulsants | 2 | 2021 | 70 | 0.890 |
Why?
|
Animals | 99 | 2024 | 169337 | 0.880 |
Why?
|
Fragile X Mental Retardation Protein | 2 | 2021 | 115 | 0.860 |
Why?
|
PTEN Phosphohydrolase | 12 | 2024 | 1119 | 0.810 |
Why?
|
rhoA GTP-Binding Protein | 3 | 2021 | 237 | 0.780 |
Why?
|
Child, Preschool | 81 | 2024 | 42650 | 0.750 |
Why?
|
Vigabatrin | 6 | 2024 | 88 | 0.750 |
Why?
|
Genetic Predisposition to Disease | 11 | 2024 | 18048 | 0.730 |
Why?
|
Chromosomes, Human, Pair 22 | 9 | 2024 | 348 | 0.730 |
Why?
|
Chromosomes, Human, Pair 16 | 3 | 2021 | 344 | 0.720 |
Why?
|
Synaptic Transmission | 3 | 2024 | 1175 | 0.700 |
Why?
|
Humans | 233 | 2024 | 768393 | 0.690 |
Why?
|
Mice | 57 | 2024 | 82017 | 0.680 |
Why?
|
Electroencephalography | 23 | 2022 | 6317 | 0.680 |
Why?
|
Hypothyroidism | 1 | 2024 | 669 | 0.660 |
Why?
|
Nerve Tissue Proteins | 10 | 2024 | 4414 | 0.660 |
Why?
|
Heat-Shock Response | 1 | 2020 | 179 | 0.650 |
Why?
|
Protein Biosynthesis | 5 | 2015 | 2094 | 0.650 |
Why?
|
Corpus Callosum | 3 | 2021 | 754 | 0.650 |
Why?
|
Receptor, EphA1 | 3 | 2010 | 20 | 0.630 |
Why?
|
Genetic Association Studies | 7 | 2024 | 2742 | 0.610 |
Why?
|
Mutation | 29 | 2024 | 30228 | 0.600 |
Why?
|
Social Isolation | 1 | 2021 | 369 | 0.600 |
Why?
|
Dendritic Spines | 3 | 2015 | 244 | 0.600 |
Why?
|
Central Nervous System Agents | 1 | 2018 | 73 | 0.590 |
Why?
|
Aconitate Hydratase | 1 | 2017 | 17 | 0.580 |
Why?
|
Magnetic Resonance Imaging | 30 | 2024 | 36849 | 0.560 |
Why?
|
Connective Tissue Growth Factor | 1 | 2017 | 91 | 0.550 |
Why?
|
Multiprotein Complexes | 10 | 2017 | 1110 | 0.550 |
Why?
|
Nerve Net | 5 | 2021 | 2362 | 0.540 |
Why?
|
Myelin Sheath | 2 | 2019 | 653 | 0.540 |
Why?
|
Phenotype | 23 | 2024 | 16721 | 0.530 |
Why?
|
Cells, Cultured | 23 | 2021 | 19022 | 0.530 |
Why?
|
Anticonvulsants | 9 | 2023 | 1923 | 0.530 |
Why?
|
Lysosomal Storage Diseases, Nervous System | 1 | 2015 | 8 | 0.530 |
Why?
|
Fasting | 1 | 2022 | 1610 | 0.520 |
Why?
|
Models, Biological | 7 | 2021 | 9493 | 0.520 |
Why?
|
Diffusion Tensor Imaging | 13 | 2024 | 2426 | 0.510 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2015 | 46 | 0.510 |
Why?
|
Infant | 55 | 2024 | 36510 | 0.510 |
Why?
|
Fetal Macrosomia | 1 | 2016 | 138 | 0.500 |
Why?
|
Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2014 | 29 | 0.490 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2015 | 55 | 0.490 |
Why?
|
Activating Transcription Factor 3 | 1 | 2015 | 62 | 0.480 |
Why?
|
Adolescent Development | 1 | 2018 | 283 | 0.480 |
Why?
|
Growth Cones | 5 | 2010 | 117 | 0.480 |
Why?
|
Mice, Knockout | 18 | 2022 | 14481 | 0.480 |
Why?
|
Ataxia | 1 | 2017 | 307 | 0.480 |
Why?
|
Child | 68 | 2024 | 80891 | 0.480 |
Why?
|
Neuroprotective Agents | 3 | 2019 | 957 | 0.480 |
Why?
|
Cystadenoma | 1 | 2014 | 77 | 0.480 |
Why?
|
Gelsolin | 1 | 2015 | 189 | 0.480 |
Why?
|
Malformations of Cortical Development | 4 | 2022 | 176 | 0.470 |
Why?
|
Male | 118 | 2024 | 364902 | 0.470 |
Why?
|
Social Behavior | 3 | 2018 | 1146 | 0.460 |
Why?
|
Neurocutaneous Syndromes | 1 | 2015 | 53 | 0.460 |
Why?
|
Motor Neurons | 3 | 2018 | 872 | 0.450 |
Why?
|
Plagiarism | 1 | 2014 | 22 | 0.450 |
Why?
|
Neural Pathways | 6 | 2019 | 3121 | 0.450 |
Why?
|
Cerebral Palsy | 4 | 2022 | 479 | 0.450 |
Why?
|
Receptors, Eph Family | 4 | 2010 | 45 | 0.440 |
Why?
|
Astrocytoma | 3 | 2020 | 780 | 0.440 |
Why?
|
Female | 118 | 2024 | 397089 | 0.440 |
Why?
|
Retinitis Pigmentosa | 1 | 2017 | 395 | 0.440 |
Why?
|
Neural Stem Cells | 2 | 2024 | 891 | 0.440 |
Why?
|
Synapses | 5 | 2018 | 1766 | 0.440 |
Why?
|
Rhabdomyoma | 3 | 2008 | 56 | 0.440 |
Why?
|
Behavior | 3 | 2015 | 543 | 0.430 |
Why?
|
DNA Repair Enzymes | 1 | 2015 | 346 | 0.430 |
Why?
|
MicroRNAs | 5 | 2018 | 3804 | 0.430 |
Why?
|
Adolescent | 56 | 2024 | 89184 | 0.430 |
Why?
|
Child Behavior | 2 | 2018 | 865 | 0.420 |
Why?
|
Angiomatosis | 1 | 2013 | 46 | 0.420 |
Why?
|
Circadian Clocks | 1 | 2015 | 168 | 0.420 |
Why?
|
Status Epilepticus | 4 | 2011 | 463 | 0.420 |
Why?
|
Genetic Testing | 6 | 2024 | 3587 | 0.410 |
Why?
|
Hemangiosarcoma | 1 | 2014 | 216 | 0.400 |
Why?
|
Nerve Fibers, Myelinated | 6 | 2015 | 953 | 0.400 |
Why?
|
Alleles | 6 | 2024 | 6892 | 0.400 |
Why?
|
Genes, Duplicate | 1 | 2012 | 31 | 0.390 |
Why?
|
Pluripotent Stem Cells | 4 | 2023 | 808 | 0.390 |
Why?
|
Child Development | 3 | 2019 | 2334 | 0.390 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2012 | 640 | 0.390 |
Why?
|
Rats | 21 | 2023 | 23835 | 0.390 |
Why?
|
Child Development Disorders, Pervasive | 6 | 2014 | 600 | 0.380 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2022 | 2890 | 0.380 |
Why?
|
Germ-Line Mutation | 5 | 2024 | 1885 | 0.370 |
Why?
|
Protein Kinases | 3 | 2014 | 1609 | 0.370 |
Why?
|
Mental Disorders | 6 | 2022 | 6876 | 0.360 |
Why?
|
Ephrin-A1 | 2 | 2010 | 9 | 0.360 |
Why?
|
Evoked Potentials | 1 | 2017 | 1058 | 0.360 |
Why?
|
Migraine Disorders | 1 | 2023 | 1713 | 0.360 |
Why?
|
Genetic Counseling | 1 | 2015 | 634 | 0.360 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 3 | 2009 | 434 | 0.360 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2014 | 598 | 0.350 |
Why?
|
Epilepsies, Partial | 4 | 2021 | 435 | 0.350 |
Why?
|
Central Nervous System Diseases | 1 | 2014 | 523 | 0.340 |
Why?
|
Heart Neoplasms | 3 | 2008 | 374 | 0.340 |
Why?
|
Adolescent Behavior | 1 | 2018 | 1190 | 0.340 |
Why?
|
Genotype | 11 | 2024 | 13042 | 0.330 |
Why?
|
Neuronal Plasticity | 2 | 2016 | 1448 | 0.330 |
Why?
|
Mice, Inbred CBA | 3 | 2021 | 438 | 0.330 |
Why?
|
Editorial Policies | 1 | 2014 | 459 | 0.320 |
Why?
|
Organoids | 3 | 2024 | 746 | 0.320 |
Why?
|
Neurogenesis | 4 | 2020 | 864 | 0.310 |
Why?
|
Stem Cells | 2 | 2020 | 3539 | 0.310 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2010 | 199 | 0.310 |
Why?
|
Metformin | 1 | 2016 | 911 | 0.310 |
Why?
|
Protein Tyrosine Phosphatases | 3 | 1995 | 458 | 0.310 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2021 | 148 | 0.310 |
Why?
|
Proteins | 8 | 2024 | 6006 | 0.300 |
Why?
|
Maze Learning | 3 | 2017 | 484 | 0.300 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2020 | 9063 | 0.300 |
Why?
|
Cognition Disorders | 4 | 2018 | 3985 | 0.300 |
Why?
|
Birth Weight | 1 | 2016 | 2114 | 0.300 |
Why?
|
Neuropeptides | 2 | 2011 | 950 | 0.290 |
Why?
|
Thyroid Neoplasms | 1 | 2021 | 2360 | 0.290 |
Why?
|
Spasm | 1 | 2008 | 131 | 0.290 |
Why?
|
Cerebral Cortex | 8 | 2024 | 5831 | 0.290 |
Why?
|
Guanine Nucleotide Exchange Factors | 4 | 2006 | 572 | 0.290 |
Why?
|
Memory | 1 | 2017 | 2210 | 0.290 |
Why?
|
Hippocampus | 6 | 2020 | 3784 | 0.280 |
Why?
|
Nervous System Diseases | 2 | 2014 | 1664 | 0.270 |
Why?
|
Heterozygote | 6 | 2021 | 2791 | 0.270 |
Why?
|
Gene Expression | 6 | 2021 | 7598 | 0.270 |
Why?
|
Anxiety | 4 | 2023 | 4677 | 0.270 |
Why?
|
Anisotropy | 10 | 2024 | 1296 | 0.260 |
Why?
|
Immunosuppressive Agents | 3 | 2018 | 4209 | 0.260 |
Why?
|
Protein Transport | 2 | 2024 | 1958 | 0.260 |
Why?
|
DNA Copy Number Variations | 4 | 2022 | 2046 | 0.260 |
Why?
|
Weight Gain | 1 | 2016 | 2356 | 0.260 |
Why?
|
Central Nervous System | 2 | 2011 | 1346 | 0.250 |
Why?
|
Circadian Rhythm | 1 | 2017 | 2588 | 0.250 |
Why?
|
Diffusion Magnetic Resonance Imaging | 7 | 2018 | 2820 | 0.250 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2014 | 1901 | 0.250 |
Why?
|
Fragile X Syndrome | 2 | 2018 | 116 | 0.250 |
Why?
|
Grooming | 2 | 2017 | 38 | 0.250 |
Why?
|
Triiodobenzoic Acids | 1 | 2005 | 123 | 0.240 |
Why?
|
Thyroiditis, Subacute | 1 | 2024 | 11 | 0.240 |
Why?
|
Pregnancy Complications | 2 | 2016 | 2972 | 0.230 |
Why?
|
Neocortex | 2 | 2020 | 417 | 0.230 |
Why?
|
Checklist | 3 | 2023 | 844 | 0.230 |
Why?
|
Cyclin-Dependent Kinase 5 | 2 | 2020 | 111 | 0.230 |
Why?
|
Embryo, Mammalian | 8 | 2011 | 1674 | 0.230 |
Why?
|
Genetic Variation | 4 | 2024 | 6606 | 0.220 |
Why?
|
Quality of Life | 2 | 2023 | 13503 | 0.220 |
Why?
|
Cell Line | 9 | 2024 | 15597 | 0.220 |
Why?
|
Young Adult | 28 | 2024 | 60049 | 0.220 |
Why?
|
Mice, Inbred C57BL | 10 | 2021 | 22355 | 0.220 |
Why?
|
Cell Movement | 2 | 2020 | 5215 | 0.220 |
Why?
|
Hypoglycemic Agents | 1 | 2016 | 3108 | 0.220 |
Why?
|
Cell Differentiation | 7 | 2024 | 11668 | 0.220 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7453 | 0.210 |
Why?
|
Granulosa Cell Tumor | 1 | 2024 | 77 | 0.210 |
Why?
|
Endometrial Hyperplasia | 1 | 2024 | 99 | 0.210 |
Why?
|
Lysosomes | 3 | 2021 | 939 | 0.210 |
Why?
|
Longitudinal Studies | 16 | 2024 | 14784 | 0.210 |
Why?
|
Hyperthyroidism | 1 | 2024 | 295 | 0.200 |
Why?
|
Lissencephaly | 2 | 2020 | 36 | 0.200 |
Why?
|
Models, Genetic | 2 | 2012 | 3442 | 0.200 |
Why?
|
Rodentia | 1 | 2024 | 262 | 0.200 |
Why?
|
Vocalization, Animal | 2 | 2012 | 95 | 0.200 |
Why?
|
Encephalitis | 3 | 2011 | 441 | 0.200 |
Why?
|
Dependovirus | 2 | 2024 | 721 | 0.200 |
Why?
|
Brain Diseases | 3 | 2018 | 1552 | 0.200 |
Why?
|
Neuropsychiatry | 2 | 2019 | 76 | 0.190 |
Why?
|
Mice, Transgenic | 10 | 2018 | 9562 | 0.190 |
Why?
|
Thyroid Hormones | 1 | 2024 | 407 | 0.190 |
Why?
|
RNA, Messenger | 4 | 2014 | 12805 | 0.190 |
Why?
|
Tyrosine | 2 | 2006 | 1428 | 0.190 |
Why?
|
Action Potentials | 2 | 2019 | 1838 | 0.190 |
Why?
|
Language Development | 2 | 2019 | 184 | 0.190 |
Why?
|
Rats, Long-Evans | 3 | 2017 | 380 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2020 | 2460 | 0.190 |
Why?
|
Evoked Potentials, Visual | 2 | 2015 | 420 | 0.190 |
Why?
|
Thyroid Diseases | 1 | 2024 | 387 | 0.180 |
Why?
|
Papilloma | 1 | 2022 | 143 | 0.180 |
Why?
|
Endocannabinoids | 1 | 2022 | 113 | 0.180 |
Why?
|
Up-Regulation | 3 | 2021 | 4142 | 0.180 |
Why?
|
Rare Diseases | 3 | 2022 | 630 | 0.180 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2020 | 2884 | 0.180 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 173 | 0.180 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2024 | 1143 | 0.180 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5800 | 0.180 |
Why?
|
Carrier Proteins | 4 | 2011 | 4936 | 0.180 |
Why?
|
Image Interpretation, Computer-Assisted | 5 | 2015 | 3411 | 0.180 |
Why?
|
Mice, 129 Strain | 1 | 2021 | 369 | 0.180 |
Why?
|
Seizures, Febrile | 2 | 2011 | 109 | 0.180 |
Why?
|
Biomedical Research | 1 | 2016 | 3464 | 0.170 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2020 | 67 | 0.170 |
Why?
|
Blood-Brain Barrier | 2 | 2024 | 1033 | 0.170 |
Why?
|
Carbamazepine | 2 | 2017 | 224 | 0.170 |
Why?
|
Organic Chemicals | 1 | 2021 | 211 | 0.170 |
Why?
|
trans-Golgi Network | 1 | 2020 | 33 | 0.170 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2012 | 2537 | 0.170 |
Why?
|
RNA, Small Interfering | 4 | 2015 | 3434 | 0.170 |
Why?
|
Pruritus | 1 | 2023 | 379 | 0.170 |
Why?
|
Multiple Sclerosis | 1 | 2015 | 3247 | 0.170 |
Why?
|
Reproducibility of Results | 13 | 2023 | 20224 | 0.170 |
Why?
|
Gene Expression Regulation | 6 | 2019 | 11918 | 0.170 |
Why?
|
Benzoquinones | 1 | 2020 | 198 | 0.170 |
Why?
|
Blotting, Western | 6 | 2015 | 5037 | 0.170 |
Why?
|
Software | 1 | 2014 | 4453 | 0.170 |
Why?
|
Pathology, Molecular | 1 | 2022 | 329 | 0.170 |
Why?
|
Penetrance | 1 | 2021 | 384 | 0.170 |
Why?
|
Oxidative Stress | 3 | 2010 | 3139 | 0.170 |
Why?
|
Glycogen Storage Disease Type II | 1 | 1999 | 43 | 0.160 |
Why?
|
Brain Neoplasms | 4 | 2020 | 9198 | 0.160 |
Why?
|
Cognition | 5 | 2021 | 7075 | 0.160 |
Why?
|
Excitatory Postsynaptic Potentials | 3 | 2016 | 369 | 0.160 |
Why?
|
Genes, Lethal | 1 | 2019 | 223 | 0.160 |
Why?
|
Computational Biology | 1 | 2011 | 3543 | 0.160 |
Why?
|
Adult | 30 | 2024 | 223640 | 0.160 |
Why?
|
Kidney Neoplasms | 2 | 2017 | 4303 | 0.160 |
Why?
|
Scalp | 2 | 2019 | 391 | 0.160 |
Why?
|
Endothelial Cells | 4 | 2022 | 3587 | 0.160 |
Why?
|
Reactive Oxygen Species | 3 | 2013 | 2146 | 0.160 |
Why?
|
Hamartoma | 1 | 2021 | 236 | 0.160 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15649 | 0.150 |
Why?
|
Age of Onset | 4 | 2024 | 3345 | 0.150 |
Why?
|
Lactams, Macrocyclic | 1 | 2020 | 319 | 0.150 |
Why?
|
Survival of Motor Neuron 2 Protein | 1 | 2018 | 49 | 0.150 |
Why?
|
Pedigree | 5 | 2022 | 4544 | 0.150 |
Why?
|
Capillaries | 1 | 2021 | 756 | 0.150 |
Why?
|
Phospholipase C beta | 2 | 2021 | 49 | 0.150 |
Why?
|
Visual Perception | 2 | 2018 | 1406 | 0.150 |
Why?
|
Research Report | 1 | 2021 | 369 | 0.150 |
Why?
|
Excitatory Amino Acid Agents | 1 | 2017 | 26 | 0.150 |
Why?
|
Gliosis | 3 | 2019 | 246 | 0.150 |
Why?
|
Ribosomes | 1 | 2021 | 499 | 0.150 |
Why?
|
Microarray Analysis | 2 | 2022 | 753 | 0.150 |
Why?
|
Fluorescent Antibody Technique | 2 | 2019 | 2475 | 0.150 |
Why?
|
Thyroid Gland | 1 | 2024 | 1172 | 0.150 |
Why?
|
Language | 3 | 2023 | 1558 | 0.140 |
Why?
|
Microcephaly | 1 | 2021 | 426 | 0.140 |
Why?
|
Neonatal Screening | 1 | 2022 | 618 | 0.140 |
Why?
|
Thalamus | 2 | 1995 | 1050 | 0.140 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2020 | 423 | 0.140 |
Why?
|
Iodine Radioisotopes | 1 | 2021 | 1035 | 0.140 |
Why?
|
Stereotypic Movement Disorder | 1 | 2017 | 31 | 0.140 |
Why?
|
Models, Neurological | 3 | 2015 | 1783 | 0.140 |
Why?
|
World Health Organization | 1 | 2023 | 1327 | 0.140 |
Why?
|
Phosphorylation | 8 | 2015 | 8326 | 0.140 |
Why?
|
Gene Frequency | 1 | 2024 | 3617 | 0.140 |
Why?
|
Infant, Newborn | 13 | 2022 | 26411 | 0.140 |
Why?
|
Vesicular Transport Proteins | 1 | 2020 | 377 | 0.140 |
Why?
|
Age Factors | 6 | 2021 | 18471 | 0.140 |
Why?
|
Mice, Inbred BALB C | 2 | 2018 | 6234 | 0.140 |
Why?
|
Species Specificity | 1 | 2021 | 2417 | 0.140 |
Why?
|
Barbiturates | 1 | 2017 | 113 | 0.140 |
Why?
|
Databases, Genetic | 1 | 2023 | 1748 | 0.140 |
Why?
|
Receptor, EphA4 | 2 | 2006 | 17 | 0.130 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2010 | 615 | 0.130 |
Why?
|
Allosteric Regulation | 1 | 2017 | 423 | 0.130 |
Why?
|
Congresses as Topic | 1 | 2021 | 810 | 0.130 |
Why?
|
Vascular Malformations | 1 | 2022 | 469 | 0.130 |
Why?
|
Segmental Duplications, Genomic | 1 | 2016 | 20 | 0.130 |
Why?
|
Ribonuclease III | 1 | 2018 | 270 | 0.130 |
Why?
|
Amino Acids | 1 | 2022 | 1716 | 0.130 |
Why?
|
Mosaicism | 2 | 2019 | 481 | 0.130 |
Why?
|
Cell Respiration | 1 | 2016 | 201 | 0.130 |
Why?
|
Angiofibroma | 1 | 2016 | 55 | 0.130 |
Why?
|
Microscopy, Atomic Force | 1 | 2016 | 251 | 0.130 |
Why?
|
Cerebellar Diseases | 1 | 2018 | 221 | 0.130 |
Why?
|
Diencephalon | 1 | 1995 | 54 | 0.130 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2017 | 183 | 0.130 |
Why?
|
Apnea | 1 | 2017 | 195 | 0.130 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2013 | 1169 | 0.130 |
Why?
|
Brain Waves | 1 | 2020 | 418 | 0.130 |
Why?
|
Coma | 2 | 2017 | 487 | 0.130 |
Why?
|
GABA Agents | 1 | 2015 | 41 | 0.130 |
Why?
|
Basal Ganglia | 1 | 2018 | 555 | 0.130 |
Why?
|
Microscopy | 1 | 2020 | 909 | 0.120 |
Why?
|
Albinism | 1 | 2015 | 25 | 0.120 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2016 | 297 | 0.120 |
Why?
|
Facial Neoplasms | 1 | 2016 | 126 | 0.120 |
Why?
|
Frameshift Mutation | 1 | 2017 | 393 | 0.120 |
Why?
|
Immunoprecipitation | 1 | 2017 | 874 | 0.120 |
Why?
|
Prospective Studies | 16 | 2024 | 54920 | 0.120 |
Why?
|
Huntington Disease | 1 | 2022 | 1147 | 0.120 |
Why?
|
rho GTP-Binding Proteins | 3 | 2005 | 279 | 0.120 |
Why?
|
Retrospective Studies | 17 | 2024 | 81801 | 0.120 |
Why?
|
Vulnerable Populations | 1 | 2020 | 718 | 0.120 |
Why?
|
3' Untranslated Regions | 2 | 2014 | 515 | 0.120 |
Why?
|
Cell Size | 3 | 2012 | 626 | 0.120 |
Why?
|
Down-Regulation | 2 | 2020 | 2940 | 0.120 |
Why?
|
Animals, Newborn | 6 | 2010 | 2695 | 0.120 |
Why?
|
Imidazoles | 2 | 2017 | 1168 | 0.120 |
Why?
|
Gene Knockdown Techniques | 3 | 2014 | 1608 | 0.120 |
Why?
|
Receptor, EphA7 | 1 | 2014 | 7 | 0.120 |
Why?
|
Pattern Recognition, Automated | 2 | 2012 | 998 | 0.120 |
Why?
|
p120 GTPase Activating Protein | 1 | 2014 | 36 | 0.120 |
Why?
|
Presynaptic Terminals | 1 | 2016 | 302 | 0.120 |
Why?
|
Endometrial Neoplasms | 1 | 2024 | 1382 | 0.120 |
Why?
|
Injections, Intraperitoneal | 1 | 2014 | 413 | 0.120 |
Why?
|
Cytoskeletal Proteins | 1 | 2020 | 1337 | 0.110 |
Why?
|
Receptor, EphB4 | 1 | 2014 | 39 | 0.110 |
Why?
|
Mutation, Missense | 2 | 2017 | 2593 | 0.110 |
Why?
|
Exodeoxyribonucleases | 1 | 2015 | 191 | 0.110 |
Why?
|
Neurites | 1 | 2016 | 390 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4588 | 0.110 |
Why?
|
Obesity | 1 | 2016 | 13084 | 0.110 |
Why?
|
Association Learning | 1 | 2015 | 223 | 0.110 |
Why?
|
Cohort Studies | 9 | 2024 | 41795 | 0.110 |
Why?
|
Aging | 3 | 2020 | 8764 | 0.110 |
Why?
|
Social Environment | 1 | 2018 | 1018 | 0.110 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2015 | 203 | 0.110 |
Why?
|
Small-Conductance Calcium-Activated Potassium Channels | 1 | 2013 | 38 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 3 | 2018 | 4076 | 0.110 |
Why?
|
Hypothalamus | 1 | 2018 | 1004 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 5 | 2015 | 8199 | 0.110 |
Why?
|
Riluzole | 1 | 2013 | 61 | 0.110 |
Why?
|
Retina | 2 | 2017 | 2661 | 0.110 |
Why?
|
Electroretinography | 1 | 2015 | 524 | 0.100 |
Why?
|
Introns | 1 | 2015 | 968 | 0.100 |
Why?
|
Oligodendroglia | 1 | 2017 | 540 | 0.100 |
Why?
|
Peroxisomes | 1 | 2013 | 67 | 0.100 |
Why?
|
Rotarod Performance Test | 1 | 2012 | 63 | 0.100 |
Why?
|
Atrophy | 2 | 2013 | 1648 | 0.100 |
Why?
|
Mitochondria | 3 | 2020 | 3675 | 0.100 |
Why?
|
Hydrocephalus | 1 | 1999 | 770 | 0.100 |
Why?
|
Ubiquitination | 1 | 2017 | 1009 | 0.100 |
Why?
|
Oligonucleotides, Antisense | 1 | 2015 | 461 | 0.100 |
Why?
|
Astrocytes | 3 | 2024 | 1349 | 0.100 |
Why?
|
Temporal Lobe | 1 | 2020 | 1728 | 0.100 |
Why?
|
Time Factors | 6 | 2020 | 40272 | 0.100 |
Why?
|
Mice, Mutant Strains | 1 | 2015 | 1755 | 0.100 |
Why?
|
Cytosol | 1 | 2015 | 886 | 0.100 |
Why?
|
Microfilament Proteins | 1 | 2017 | 1135 | 0.100 |
Why?
|
Cross-Sectional Studies | 7 | 2023 | 26375 | 0.100 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2015 | 3794 | 0.100 |
Why?
|
Retinal Pigment Epithelium | 1 | 2015 | 309 | 0.100 |
Why?
|
Stem Cell Factor | 1 | 2012 | 194 | 0.100 |
Why?
|
Receptors, Opioid | 1 | 1992 | 145 | 0.100 |
Why?
|
Receptors, Muscarinic | 1 | 1992 | 157 | 0.100 |
Why?
|
Animals, Genetically Modified | 2 | 2020 | 1563 | 0.100 |
Why?
|
Hand | 1 | 2017 | 912 | 0.100 |
Why?
|
Gene Knockout Techniques | 2 | 2012 | 808 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1614 | 0.100 |
Why?
|
Genes | 1 | 2015 | 1824 | 0.100 |
Why?
|
Contrast Media | 1 | 2005 | 5336 | 0.100 |
Why?
|
Treatment Outcome | 12 | 2024 | 65379 | 0.100 |
Why?
|
Sequence Deletion | 1 | 2016 | 1497 | 0.090 |
Why?
|
Transfection | 3 | 2015 | 5764 | 0.090 |
Why?
|
Cell Shape | 1 | 2012 | 371 | 0.090 |
Why?
|
Immunohistochemistry | 4 | 2017 | 11120 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2021 | 2635 | 0.090 |
Why?
|
Clinical Trials as Topic | 3 | 2016 | 8051 | 0.090 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2015 | 632 | 0.090 |
Why?
|
N-Methylaspartate | 1 | 2011 | 231 | 0.090 |
Why?
|
Metabolic Networks and Pathways | 1 | 2015 | 798 | 0.090 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2014 | 677 | 0.090 |
Why?
|
Immunity, Active | 1 | 2010 | 58 | 0.090 |
Why?
|
Reflex | 1 | 2012 | 375 | 0.090 |
Why?
|
Neuropsychological Tests | 6 | 2023 | 7145 | 0.090 |
Why?
|
Goals | 1 | 2016 | 716 | 0.090 |
Why?
|
Apoptosis | 5 | 2012 | 9516 | 0.090 |
Why?
|
Trisomy | 1 | 2012 | 260 | 0.090 |
Why?
|
Amygdala | 1 | 2018 | 1382 | 0.090 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2012 | 294 | 0.090 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2015 | 775 | 0.090 |
Why?
|
Prenatal Diagnosis | 2 | 2008 | 1274 | 0.090 |
Why?
|
Genetic Engineering | 1 | 2016 | 936 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3906 | 0.090 |
Why?
|
Cerebellar Cortex | 1 | 1990 | 108 | 0.080 |
Why?
|
Family Health | 1 | 2015 | 1255 | 0.080 |
Why?
|
HEK293 Cells | 3 | 2014 | 4291 | 0.080 |
Why?
|
Interpersonal Relations | 1 | 2017 | 1440 | 0.080 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2010 | 139 | 0.080 |
Why?
|
Cataract | 1 | 2015 | 837 | 0.080 |
Why?
|
GPI-Linked Proteins | 1 | 2011 | 473 | 0.080 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1232 | 0.080 |
Why?
|
Pregnancy | 5 | 2022 | 30200 | 0.080 |
Why?
|
Image Enhancement | 3 | 2015 | 2894 | 0.080 |
Why?
|
Transcription Factor CHOP | 1 | 2009 | 69 | 0.080 |
Why?
|
Tunicamycin | 1 | 2009 | 109 | 0.080 |
Why?
|
Glucose Transporter Type 1 | 1 | 2009 | 186 | 0.080 |
Why?
|
Models, Anatomic | 1 | 2013 | 684 | 0.080 |
Why?
|
Echinococcus granulosus | 1 | 2008 | 11 | 0.080 |
Why?
|
Arthrogryposis | 1 | 2009 | 69 | 0.080 |
Why?
|
Ephrins | 2 | 2005 | 28 | 0.080 |
Why?
|
Receptors, Nicotinic | 1 | 1992 | 494 | 0.080 |
Why?
|
Lentivirus | 1 | 2012 | 519 | 0.080 |
Why?
|
Echinococcosis, Hepatic | 1 | 2008 | 23 | 0.080 |
Why?
|
Subtraction Technique | 1 | 2012 | 519 | 0.080 |
Why?
|
Chimerin 1 | 1 | 2008 | 13 | 0.080 |
Why?
|
Pyridines | 2 | 2017 | 2889 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2661 | 0.080 |
Why?
|
Haploinsufficiency | 1 | 2010 | 336 | 0.080 |
Why?
|
Threonine | 1 | 2009 | 274 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 474 | 0.080 |
Why?
|
Cell Count | 1 | 2012 | 1833 | 0.080 |
Why?
|
Pain | 1 | 2023 | 5103 | 0.080 |
Why?
|
Brain Mapping | 4 | 2021 | 6740 | 0.080 |
Why?
|
Cytoplasmic Granules | 1 | 2011 | 573 | 0.080 |
Why?
|
Oncogene Protein v-akt | 1 | 2008 | 130 | 0.080 |
Why?
|
In Situ Hybridization | 4 | 2001 | 1905 | 0.080 |
Why?
|
Sesquiterpenes | 1 | 2009 | 177 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 478 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2018 | 10776 | 0.070 |
Why?
|
Duane Retraction Syndrome | 1 | 2008 | 59 | 0.070 |
Why?
|
Hypopigmentation | 1 | 2008 | 43 | 0.070 |
Why?
|
Zebrafish | 3 | 2020 | 3037 | 0.070 |
Why?
|
Zebrafish Proteins | 1 | 2014 | 1019 | 0.070 |
Why?
|
Prefrontal Cortex | 1 | 2018 | 2257 | 0.070 |
Why?
|
Video Recording | 3 | 2018 | 974 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3666 | 0.070 |
Why?
|
Motor Activity | 1 | 2017 | 2720 | 0.070 |
Why?
|
Syndrome | 3 | 2009 | 3275 | 0.070 |
Why?
|
Middle Aged | 9 | 2024 | 223491 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10654 | 0.070 |
Why?
|
Chick Embryo | 2 | 2008 | 975 | 0.070 |
Why?
|
Sleep | 2 | 2020 | 4802 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4907 | 0.070 |
Why?
|
Models, Statistical | 3 | 2018 | 5099 | 0.070 |
Why?
|
Lactones | 1 | 2009 | 316 | 0.070 |
Why?
|
Retinal Ganglion Cells | 2 | 2010 | 811 | 0.070 |
Why?
|
Heme Oxygenase-1 | 1 | 2009 | 365 | 0.070 |
Why?
|
Pattern Recognition, Visual | 1 | 2012 | 825 | 0.070 |
Why?
|
Exercise | 1 | 2023 | 5946 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2022 | 3279 | 0.070 |
Why?
|
Face | 1 | 2012 | 1031 | 0.070 |
Why?
|
Pregnancy, High-Risk | 1 | 2007 | 121 | 0.070 |
Why?
|
Sensitivity and Specificity | 7 | 2017 | 14737 | 0.070 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2006 | 203 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2016 | 1891 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4069 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2005 | 2750 | 0.070 |
Why?
|
Transduction, Genetic | 1 | 2009 | 902 | 0.070 |
Why?
|
Endoplasmic Reticulum | 2 | 2009 | 1131 | 0.060 |
Why?
|
Abnormalities, Multiple | 2 | 2011 | 1424 | 0.060 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4120 | 0.060 |
Why?
|
Receptor Aggregation | 1 | 2005 | 72 | 0.060 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2010 | 607 | 0.060 |
Why?
|
Maternal Exposure | 1 | 2012 | 1079 | 0.060 |
Why?
|
Visual Pathways | 1 | 2010 | 559 | 0.060 |
Why?
|
Transcription Factors | 5 | 2021 | 12166 | 0.060 |
Why?
|
Cytoplasm | 1 | 2010 | 1502 | 0.060 |
Why?
|
Serine | 1 | 2009 | 831 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15939 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8562 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2020 | 7880 | 0.060 |
Why?
|
Neovascularization, Physiologic | 1 | 2012 | 1371 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2015 | 7599 | 0.060 |
Why?
|
Organ Size | 3 | 2018 | 2268 | 0.060 |
Why?
|
Caenorhabditis elegans | 2 | 2013 | 1467 | 0.060 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2006 | 414 | 0.060 |
Why?
|
Demyelinating Diseases | 1 | 2007 | 358 | 0.060 |
Why?
|
Gene Deletion | 1 | 2012 | 2673 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12778 | 0.060 |
Why?
|
Nervous System Malformations | 1 | 2006 | 244 | 0.060 |
Why?
|
Bicuculline | 2 | 2016 | 96 | 0.060 |
Why?
|
Registries | 1 | 2020 | 8379 | 0.060 |
Why?
|
Amino Acid Sequence | 5 | 2008 | 13423 | 0.060 |
Why?
|
Genetic Vectors | 2 | 2024 | 3413 | 0.060 |
Why?
|
Caregivers | 1 | 2016 | 2303 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 3520 | 0.050 |
Why?
|
Flow Cytometry | 2 | 2016 | 5900 | 0.050 |
Why?
|
Parents | 3 | 2022 | 3596 | 0.050 |
Why?
|
Consensus | 2 | 2023 | 3212 | 0.050 |
Why?
|
Stress, Physiological | 1 | 2011 | 1410 | 0.050 |
Why?
|
Melanoma | 1 | 2022 | 5705 | 0.050 |
Why?
|
Genes, Dominant | 2 | 2021 | 856 | 0.050 |
Why?
|
Nerve Regeneration | 1 | 2008 | 799 | 0.050 |
Why?
|
Blotting, Northern | 2 | 1995 | 1553 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2023 | 171 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.050 |
Why?
|
ROC Curve | 2 | 2021 | 3623 | 0.050 |
Why?
|
DNA-Binding Proteins | 3 | 2021 | 9614 | 0.050 |
Why?
|
United States | 6 | 2024 | 73150 | 0.050 |
Why?
|
Poloxamer | 1 | 2022 | 56 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2011 | 3731 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
Paraplegia | 1 | 2023 | 161 | 0.050 |
Why?
|
Algorithms | 5 | 2018 | 14154 | 0.050 |
Why?
|
Infant, Newborn, Diseases | 1 | 2008 | 591 | 0.050 |
Why?
|
Comorbidity | 3 | 2023 | 10588 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5857 | 0.050 |
Why?
|
Retinoids | 1 | 2022 | 99 | 0.050 |
Why?
|
Prevalence | 4 | 2021 | 15872 | 0.050 |
Why?
|
Monoacylglycerol Lipases | 1 | 2022 | 30 | 0.050 |
Why?
|
Fatal Outcome | 1 | 2007 | 1837 | 0.050 |
Why?
|
Psychometrics | 2 | 2023 | 3069 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2015 | 3827 | 0.050 |
Why?
|
Risk Factors | 5 | 2020 | 74962 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6993 | 0.050 |
Why?
|
Gangliosides | 1 | 2022 | 132 | 0.050 |
Why?
|
Pilot Projects | 3 | 2022 | 8731 | 0.050 |
Why?
|
Mutant Proteins | 1 | 2023 | 489 | 0.050 |
Why?
|
Muscle Spasticity | 1 | 2022 | 159 | 0.050 |
Why?
|
Calpain | 1 | 2022 | 147 | 0.050 |
Why?
|
Axonal Transport | 1 | 2022 | 178 | 0.050 |
Why?
|
Pentobarbital | 1 | 2001 | 153 | 0.050 |
Why?
|
Stereotyped Behavior | 1 | 2021 | 135 | 0.050 |
Why?
|
Drug Therapy, Combination | 2 | 2001 | 6318 | 0.050 |
Why?
|
Cerebellar Nuclei | 1 | 2021 | 54 | 0.050 |
Why?
|
Sphingolipids | 1 | 2022 | 178 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39407 | 0.050 |
Why?
|
Fetal Proteins | 1 | 2001 | 99 | 0.050 |
Why?
|
Cell Survival | 4 | 2012 | 5792 | 0.050 |
Why?
|
Endocytosis | 1 | 2005 | 959 | 0.040 |
Why?
|
Brain Edema | 1 | 2005 | 607 | 0.040 |
Why?
|
Adaptor Protein Complex beta Subunits | 1 | 2020 | 13 | 0.040 |
Why?
|
Anesthesia | 1 | 2011 | 1596 | 0.040 |
Why?
|
Intelligence Tests | 1 | 2021 | 505 | 0.040 |
Why?
|
Muscle Hypotonia | 1 | 2021 | 166 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2952 | 0.040 |
Why?
|
Actins | 2 | 2005 | 2059 | 0.040 |
Why?
|
Cytoskeleton | 1 | 2005 | 1176 | 0.040 |
Why?
|
Midazolam | 1 | 2001 | 267 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2012 | 4427 | 0.040 |
Why?
|
Polymerase Chain Reaction | 3 | 2011 | 6085 | 0.040 |
Why?
|
Centrioles | 1 | 2020 | 80 | 0.040 |
Why?
|
Globus Pallidus | 1 | 2021 | 250 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12241 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15455 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2023 | 469 | 0.040 |
Why?
|
HLA Antigens | 1 | 2024 | 1337 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5512 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 2001 | 397 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 433 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3458 | 0.040 |
Why?
|
Fibroblasts | 3 | 2020 | 4177 | 0.040 |
Why?
|
Intelligence | 1 | 2023 | 929 | 0.040 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 1999 | 187 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2009 | 3612 | 0.040 |
Why?
|
Biological Assay | 1 | 2021 | 627 | 0.040 |
Why?
|
Hedgehog Proteins | 1 | 2022 | 770 | 0.040 |
Why?
|
Hallucinations | 1 | 2000 | 375 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2019 | 22296 | 0.040 |
Why?
|
Hemodiafiltration | 1 | 2017 | 19 | 0.040 |
Why?
|
Photic Stimulation | 2 | 2015 | 2004 | 0.040 |
Why?
|
Telemetry | 1 | 2018 | 200 | 0.040 |
Why?
|
Subcellular Fractions | 1 | 2018 | 527 | 0.040 |
Why?
|
Health Priorities | 1 | 2020 | 380 | 0.040 |
Why?
|
Drug Resistance | 1 | 2003 | 1595 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13697 | 0.040 |
Why?
|
Learning | 2 | 2019 | 1761 | 0.040 |
Why?
|
Los Angeles | 1 | 2017 | 245 | 0.030 |
Why?
|
Facies | 1 | 2017 | 224 | 0.030 |
Why?
|
Prognosis | 4 | 2018 | 30022 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2024 | 1667 | 0.030 |
Why?
|
Decontamination | 1 | 2017 | 73 | 0.030 |
Why?
|
Germ Cells | 1 | 2021 | 643 | 0.030 |
Why?
|
Protein Kinase C | 1 | 2021 | 1207 | 0.030 |
Why?
|
DNA Primers | 2 | 2008 | 2825 | 0.030 |
Why?
|
2-Amino-5-phosphonovalerate | 1 | 2016 | 57 | 0.030 |
Why?
|
Aorta | 1 | 2024 | 2046 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2022 | 873 | 0.030 |
Why?
|
Plasmapheresis | 1 | 2017 | 207 | 0.030 |
Why?
|
Immune System | 1 | 2022 | 801 | 0.030 |
Why?
|
Headache | 1 | 2024 | 1262 | 0.030 |
Why?
|
Long-Term Synaptic Depression | 1 | 2016 | 59 | 0.030 |
Why?
|
Cycloheximide | 1 | 2016 | 342 | 0.030 |
Why?
|
Ligands | 2 | 2014 | 3283 | 0.030 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 3 | 1 | 1995 | 4 | 0.030 |
Why?
|
Dendrites | 2 | 2009 | 472 | 0.030 |
Why?
|
Zinc Fingers | 1 | 1998 | 577 | 0.030 |
Why?
|
Neuroglia | 1 | 2022 | 960 | 0.030 |
Why?
|
Wavelet Analysis | 1 | 2015 | 56 | 0.030 |
Why?
|
Microscopy, Confocal | 2 | 2016 | 1974 | 0.030 |
Why?
|
Conditioning, Eyelid | 1 | 2015 | 9 | 0.030 |
Why?
|
Information Theory | 1 | 2015 | 49 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12092 | 0.030 |
Why?
|
Propofol | 1 | 2001 | 608 | 0.030 |
Why?
|
Affect | 1 | 2023 | 1501 | 0.030 |
Why?
|
Elastic Modulus | 1 | 2016 | 211 | 0.030 |
Why?
|
Computer Simulation | 3 | 2015 | 6277 | 0.030 |
Why?
|
Gestational Age | 2 | 1995 | 3615 | 0.030 |
Why?
|
Sickness Impact Profile | 1 | 2016 | 299 | 0.030 |
Why?
|
Mice, Nude | 1 | 2021 | 3632 | 0.030 |
Why?
|
Thalamic Nuclei | 1 | 1995 | 111 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2001 | 1445 | 0.030 |
Why?
|
Growth Substances | 1 | 2017 | 761 | 0.030 |
Why?
|
Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2014 | 13 | 0.030 |
Why?
|
Motion | 1 | 2018 | 789 | 0.030 |
Why?
|
Skin Diseases | 1 | 2023 | 1084 | 0.030 |
Why?
|
Testis | 1 | 1998 | 783 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2024 | 2168 | 0.030 |
Why?
|
Glutathione | 1 | 2017 | 585 | 0.030 |
Why?
|
Ephrin-A5 | 1 | 2014 | 17 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1078 | 0.030 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2016 | 361 | 0.030 |
Why?
|
DNA, Complementary | 2 | 1998 | 1992 | 0.030 |
Why?
|
Aged | 6 | 2024 | 171562 | 0.030 |
Why?
|
Periventricular Nodular Heterotopia | 1 | 2014 | 57 | 0.030 |
Why?
|
Skin | 2 | 2023 | 4499 | 0.030 |
Why?
|
Microtubules | 1 | 2020 | 1071 | 0.030 |
Why?
|
Antisense Elements (Genetics) | 1 | 1993 | 37 | 0.030 |
Why?
|
Dark Adaptation | 1 | 2015 | 224 | 0.030 |
Why?
|
Muscular Dystrophy, Animal | 1 | 2014 | 89 | 0.030 |
Why?
|
RNA Probes | 1 | 1993 | 111 | 0.030 |
Why?
|
Molecular Sequence Data | 4 | 2008 | 17626 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 1672 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2019 | 562 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1628 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2019 | 790 | 0.030 |
Why?
|
Insulin | 1 | 2008 | 6607 | 0.030 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2015 | 534 | 0.030 |
Why?
|
Statistical Distributions | 1 | 2013 | 63 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2005 | 4537 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2008 | 20765 | 0.030 |
Why?
|
Metabolomics | 1 | 2022 | 1674 | 0.030 |
Why?
|
Base Sequence | 3 | 2008 | 12422 | 0.030 |
Why?
|
Embryonic and Fetal Development | 1 | 1993 | 420 | 0.030 |
Why?
|
RNA Interference | 2 | 2012 | 2836 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2001 | 4859 | 0.030 |
Why?
|
Histology | 1 | 2012 | 16 | 0.030 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1992 | 19 | 0.030 |
Why?
|
Acute Disease | 1 | 2003 | 7242 | 0.030 |
Why?
|
Synapsins | 1 | 2012 | 43 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 13020 | 0.030 |
Why?
|
Two-Hybrid System Techniques | 2 | 2005 | 461 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2017 | 1195 | 0.020 |
Why?
|
Societies, Medical | 1 | 2024 | 3960 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2023 | 5313 | 0.020 |
Why?
|
Enkephalins | 1 | 1992 | 139 | 0.020 |
Why?
|
Survival | 1 | 2012 | 160 | 0.020 |
Why?
|
Echocardiography | 1 | 2024 | 5044 | 0.020 |
Why?
|
Self Report | 1 | 2023 | 3766 | 0.020 |
Why?
|
RNA | 1 | 2021 | 2726 | 0.020 |
Why?
|
Pyramidal Cells | 1 | 2014 | 367 | 0.020 |
Why?
|
Wakefulness | 1 | 2018 | 1283 | 0.020 |
Why?
|
Biopsy | 1 | 2003 | 6808 | 0.020 |
Why?
|
Language Disorders | 1 | 2012 | 140 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2014 | 539 | 0.020 |
Why?
|
Autoradiography | 1 | 1992 | 732 | 0.020 |
Why?
|
Sodium Compounds | 1 | 2011 | 35 | 0.020 |
Why?
|
Iron | 1 | 2020 | 1814 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2016 | 1743 | 0.020 |
Why?
|
Motor Skills | 1 | 2014 | 523 | 0.020 |
Why?
|
Gene Expression Profiling | 3 | 2014 | 9510 | 0.020 |
Why?
|
Vision, Ocular | 1 | 2014 | 458 | 0.020 |
Why?
|
Receptors, Opioid, mu | 1 | 1992 | 171 | 0.020 |
Why?
|
Arsenites | 1 | 2011 | 65 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1992 | 2087 | 0.020 |
Why?
|
CA1 Region, Hippocampal | 1 | 2011 | 110 | 0.020 |
Why?
|
Sample Size | 1 | 2014 | 848 | 0.020 |
Why?
|
Gene Library | 1 | 1993 | 1061 | 0.020 |
Why?
|
Horseradish Peroxidase | 1 | 1990 | 170 | 0.020 |
Why?
|
PC12 Cells | 1 | 2011 | 317 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2862 | 0.020 |
Why?
|
Organ Specificity | 1 | 1995 | 1967 | 0.020 |
Why?
|
Poly I-C | 1 | 2010 | 111 | 0.020 |
Why?
|
Benzamides | 1 | 2016 | 1380 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13646 | 0.020 |
Why?
|
Cytoprotection | 1 | 2011 | 200 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2011 | 178 | 0.020 |
Why?
|
HeLa Cells | 2 | 2006 | 3088 | 0.020 |
Why?
|
Adenylate Kinase | 1 | 2010 | 102 | 0.020 |
Why?
|
Carbohydrate Metabolism, Inborn Errors | 1 | 2009 | 32 | 0.020 |
Why?
|
Dentate Gyrus | 1 | 2010 | 165 | 0.020 |
Why?
|
Artifacts | 1 | 2018 | 1930 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5878 | 0.020 |
Why?
|
Exploratory Behavior | 1 | 2010 | 276 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2017 | 1943 | 0.020 |
Why?
|
Cats | 1 | 1990 | 978 | 0.020 |
Why?
|
Lithium Chloride | 1 | 2009 | 83 | 0.020 |
Why?
|
Chemotaxis | 1 | 2012 | 600 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 1990 | 405 | 0.020 |
Why?
|
Nerve Crush | 1 | 2008 | 77 | 0.020 |
Why?
|
Axotomy | 1 | 2008 | 71 | 0.020 |
Why?
|
Isoenzymes | 1 | 1993 | 1684 | 0.020 |
Why?
|
Light | 1 | 2015 | 1354 | 0.020 |
Why?
|
Abducens Nerve | 1 | 2008 | 28 | 0.020 |
Why?
|
Ribosomal Protein S6 | 1 | 2008 | 70 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3440 | 0.020 |
Why?
|
Granulocytes | 1 | 1990 | 550 | 0.020 |
Why?
|
Angelman Syndrome | 1 | 2010 | 139 | 0.020 |
Why?
|
Blood Vessels | 1 | 2014 | 1110 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4450 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2014 | 924 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9379 | 0.020 |
Why?
|
Oculomotor Nerve | 1 | 2008 | 72 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12456 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2009 | 612 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2011 | 2559 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9682 | 0.020 |
Why?
|
Phenylbutyrates | 1 | 2008 | 72 | 0.020 |
Why?
|
DNA | 1 | 2021 | 7211 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2017 | 1802 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2017 | 6510 | 0.020 |
Why?
|
Electroporation | 1 | 2008 | 236 | 0.020 |
Why?
|
eIF-2 Kinase | 1 | 2008 | 147 | 0.020 |
Why?
|
Homozygote | 1 | 2012 | 1779 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 24318 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2009 | 559 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2008 | 2911 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2014 | 1539 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2011 | 742 | 0.020 |
Why?
|
Nicotine | 1 | 1992 | 680 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2015 | 2528 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2016 | 1876 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2007 | 424 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9636 | 0.020 |
Why?
|
Reaction Time | 1 | 2012 | 2103 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2008 | 558 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8506 | 0.020 |
Why?
|
Pyrazoles | 1 | 2016 | 2021 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13323 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2537 | 0.020 |
Why?
|
Cell Death | 1 | 2011 | 1682 | 0.020 |
Why?
|
Optic Nerve | 1 | 2008 | 571 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3413 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2022 | 4875 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2636 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 16028 | 0.010 |
Why?
|
Patch-Clamp Techniques | 1 | 2006 | 927 | 0.010 |
Why?
|
Oculomotor Muscles | 1 | 2008 | 405 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2006 | 784 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2006 | 839 | 0.010 |
Why?
|
Neoplasms | 2 | 2010 | 22385 | 0.010 |
Why?
|
Genetic Techniques | 1 | 2006 | 428 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1249 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2008 | 1064 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2830 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2017 | 3541 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5916 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9371 | 0.010 |
Why?
|
Autoantibodies | 1 | 2011 | 2126 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1151 | 0.010 |
Why?
|
Hypoglycemia | 1 | 2009 | 894 | 0.010 |
Why?
|
Protein Binding | 1 | 2013 | 9343 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2006 | 3587 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8753 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2006 | 2524 | 0.010 |
Why?
|
Cell Membrane | 1 | 2008 | 3663 | 0.010 |
Why?
|
Body Weight | 1 | 2009 | 4629 | 0.010 |
Why?
|
Cell Communication | 1 | 2005 | 1660 | 0.010 |
Why?
|
Immunoblotting | 1 | 2001 | 1647 | 0.010 |
Why?
|
Brain Chemistry | 1 | 2001 | 962 | 0.010 |
Why?
|
Spermatogenesis | 1 | 1998 | 259 | 0.010 |
Why?
|
Spinal Cord | 1 | 2005 | 1813 | 0.010 |
Why?
|
Eye | 1 | 2001 | 712 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2001 | 4168 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2006 | 4775 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 3779 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2008 | 3981 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1990 | 9261 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2009 | 10478 | 0.010 |
Why?
|
Phylogeny | 1 | 2001 | 2843 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 12870 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2008 | 15881 | 0.000 |
Why?
|